posit
individu
resid
estim
burden
respiratori
infect
hivposit
patient
africa
therefor
crucial
guid
health
decis
make
effici
control
arti
africa
date
influenza
vaccin
integr
immun
program
almost
african
countri
addit
immin
avail
human
respiratori
syncyti
viru
vaccin
necessari
set
prioriti
vaccin
manag
acut
respiratori
infect
africa
particularli
peopl
live
hiv
although
sever
studi
africa
contribut
show
greater
sever
respiratori
infect
among
hiv
posit
peopl
current
systemat
review
metaanalysi
compar
case
fatal
rate
cfr
hivposit
neg
individu
respiratori
tract
infect
contin
level
compar
hivposit
neg
individu
regard
arti
would
help
know
direct
specif
intervent
need
identifi
differ
would
help
know
direct
specif
strategi
need
peopl
live
hiv
therefor
best
knowledg
conduct
first
systemat
review
metaanalysi
investig
whether
current
data
may
suggest
specif
attent
hivposit
individu
aim
better
control
prevent
strategi
acut
respiratori
infect
specif
aim
compar
proport
viral
aetiolog
acut
respiratori
tract
infect
africa
hivposit
variafricahiv
hivneg
popul
also
aim
compar
cfr
hivposit
hivneg
popul
acut
respiratori
tract
infect
arti
systemat
review
metaanalysi
report
follow
prisma
guidelin
illustr
checklist
supplementari
tabl
systemat
review
regist
prospero
consid
crosssect
case
control
cohort
studi
includ
hivposit
hivneg
popul
arti
resid
africa
regardless
age
ethnic
primari
outcom
interest
case
fatal
rate
secondari
outcom
proport
respiratori
viral
aetiolog
arti
respiratori
virus
identifi
polymeras
chain
reaction
techniqu
pcr
studi
conduct
outbreak
period
studi
includ
hiv
posit
peopl
hiv
neg
peopl
exclud
comprehens
search
electron
databas
among
medlin
pubm
excerpta
medica
databas
african
journal
onlin
web
knowledg
global
index
medicu
search
strategi
adapt
suit
databas
illustr
search
pubm
supplementari
tabl
consid
studi
publish
st
januari
april
without
languag
restrict
arbitrari
limit
contemporan
recent
data
sinc
epidemiolog
hiv
infect
drastic
chang
last
year
supplement
electron
search
refer
relev
studi
also
screen
potenti
consider
two
review
author
sk
afm
independ
screen
titl
abstract
aggreg
citat
retriev
electron
search
full
text
potenti
elig
articl
assess
inclus
disagr
resolv
discuss
unreach
consensu
resolv
third
review
author
jjb
kappa
statist
use
estim
agreement
studi
select
review
author
discuss
data
extract
independ
two
review
author
sk
afm
doubl
check
third
review
author
jjb
accuraci
case
miss
data
articl
author
articl
contact
request
unreport
detail
data
extract
includ
descript
articl
name
first
author
year
public
studi
characterist
studi
design
sampl
method
time
data
collect
period
particip
recruit
set
locat
countri
region
accord
unit
nation
statist
divis
particip
characterist
clinic
present
type
sampl
use
viral
detect
meanmedian
age
age
group
proport
male
proport
respiratori
viral
aetiolog
arti
case
fatal
rate
hiv
posit
hiv
neg
group
enough
data
comput
estim
methodolog
qualiti
studi
assess
use
newcastl
ottawa
scale
score
question
scale
ye
assign
item
total
score
articl
accord
total
score
obtain
articl
classifi
high
risk
point
moder
risk
point
low
risk
bia
point
assess
done
two
review
author
sk
jjb
discrep
resolv
discuss
consensu
kappa
statist
use
investig
agreement
review
author
discuss
data
metaanalys
use
packag
meta
version
r
version
r
foundat
statist
comput
randomeffect
metaanalysi
mantelhaenszel
mh
method
use
assess
associ
hiv
infect
case
fatal
rate
viral
aetiolog
report
pool
weight
odd
ratio
confid
predict
interv
symmetri
counterenhanc
funnel
plot
outcom
studi
harbord
test
use
assess
report
public
bia
consider
signific
public
bia
threshold
p
heterogen
across
studi
assess
cochran
q
test
report
statist
case
substanti
heterogen
subgroupanalysi
peopl
age
year
versu
year
adult
year
versu
children
unsd
region
investig
possibl
sourc
residu
heterogen
initi
identifi
record
final
full
text
retain
review
includ
metaanalysi
fig
interrat
agreement
studi
select
high
includ
studi
low
risk
bia
moder
risk
bia
none
high
risk
bia
total
particip
includ
data
nine
countri
data
western
northern
africa
one
studi
central
africa
eastern
africa
southern
africa
tabl
howev
sinc
major
area
contain
region
high
statist
signific
reduc
plausibl
public
bia
underli
caus
funnel
asymmetri
howev
adjust
trimandfil
method
supplementari
fig
pool
ci
ad
studi
supplementari
tabl
sensit
analysi
includ
low
risk
bia
studi
yield
find
close
crude
analysi
pool
ci
studi
subgroup
analysi
strength
associ
hivinfect
cfr
significantli
higher
among
children
year
pool
ci
compar
peopl
age
year
pool
ci
p
supplementari
fig
differ
children
year
adult
supplementari
figur
region
supplementari
figur
total
particip
includ
analysi
viral
aetiolog
differ
viral
respiratori
aetiolog
enteroviru
human
adenoviru
human
bocaviru
human
coronaviru
human
parainfluenza
viru
influenza
viru
human
metapneumoviru
respiratori
syncyti
viru
arti
hiv
posit
hiv
neg
peopl
except
rhinoviru
hivposit
person
less
like
infect
rhinoviru
hivneg
pool
ci
fig
figur
detail
studi
appendix
supplementari
figur
funnel
plot
human
adenoviru
respiratori
syncyti
viru
human
parainfluenza
viru
influenza
viru
human
metapneumoviru
present
supplementari
figur
respect
public
bia
virus
except
human
parainfluenza
viru
human
metapneumoviru
supplementari
tabl
tabl
subgroup
analysi
differ
children
adult
respiratori
virus
supplementari
tabl
tabl
best
knowledg
first
systemat
review
metaanalysi
compar
cfr
hivposit
neg
peopl
arti
africa
also
investig
associ
hiv
infect
viral
aetiolog
arti
africa
key
find
review
includ
higher
rate
mortal
hiv
posit
peopl
compar
hiv
neg
burden
higher
among
age
year
anoth
key
find
gener
differ
viral
aetiolog
arti
hiv
posit
hiv
neg
peopl
except
rhinoviru
less
associ
hiv
infect
communic
noncommunic
diseas
hiv
posit
individu
arti
higher
risk
death
compar
hiv
neg
individu
explan
lie
global
immun
respons
work
antiretrovir
therapi
immun
respons
hiv
posit
patient
ari
may
includ
low
level
antibodi
low
level
cell
potenti
immunolog
dysfunct
may
promot
increas
mortal
group
patient
specif
pathogenesi
may
explain
associ
hiv
infect
increas
risk
death
patient
acut
respiratori
infect
well
understood
unlik
review
studi
conduct
outsid
africa
suggest
presenc
hiv
infect
influenc
clinic
outcom
peopl
arti
differ
explain
fact
peopl
live
hiv
africa
compar
develop
countri
experi
limit
access
healthcar
advanc
hiv
diseas
malnutrit
parasit
diseas
low
antiretrovir
treatment
coverag
therefor
african
context
higher
risk
death
peopl
hiv
explain
hiv
infect
found
increas
risk
death
among
children
year
find
close
gener
popul
children
inde
arti
disproportion
effect
children
younger
year
increas
risk
death
disabilityadjust
lifeyear
increas
mortal
among
popul
may
relat
immatur
immun
respons
compar
adult
especi
case
hiv
infect
addit
evid
support
adher
antiretrovir
therapi
lower
children
compar
adult
antiretrovir
therapi
key
compon
curb
mortal
hiv
posit
peopl
children
five
suboptim
observ
antiretrovir
therapi
addit
weak
immun
respons
case
arti
therefor
present
higher
risk
death
compar
adult
lack
differ
respiratori
viru
arti
hivposit
neg
individu
suggest
differ
germ
lead
arti
may
come
other
bacteria
fungi
includ
tuberculosi
pneumocysti
jirovecii
inde
hivposit
neg
individu
live
ecosystem
therefor
contamin
commun
air
transmiss
microorgan
strategi
curb
burden
diseas
relat
arti
effort
control
respiratori
viral
infect
term
viral
aetiolog
hiv
posit
neg
individu
find
demonstr
arti
deserv
attent
hiv
healthcar
provid
research
polici
maker
stakehold
improv
detect
overal
proper
manag
effici
control
arti
peopl
hiv
africa
especi
children
although
strategi
curb
burden
arti
coordin
made
advanc
toward
reduc
childhood
mortal
lrti
hiv
epidem
reduc
effort
made
far
reduct
morbid
mortal
arti
africa
focu
hiv
infect
also
requir
multifacet
approach
includ
address
risk
factor
like
smoke
second
hand
smoke
indoor
pollut
undernutrit
especi
among
children
five
year
old
strategi
curb
burden
among
hiv
posit
individu
includ
use
viral
conjug
bacteri
vaccin
reduc
colon
consequ
microbiolog
load
environ
hiv
posit
individu
indic
among
hivposit
individu
healthcar
provid
adher
guidelin
chemoprophylaxi
cotrimoxazol
prevent
among
other
respiratori
infect
among
peopl
live
hiv
improv
immun
hiv
posit
individu
routin
micronutri
supplement
especi
multivitamin
use
multivitamin
shown
benefit
reduc
preval
arti
hiv
posit
peopl
one
import
point
curb
burden
arti
earli
initi
antiretrovir
treatment
among
hiv
posit
peopl
regardless
cell
count
age
recommend
world
health
organ
antiretrovir
treatment
shown
reduc
frequenc
opportunist
infect
significantli
reduc
hivrel
mortal
includ
among
peopl
respiratori
tract
infect
howev
implement
guidelin
remain
challeng
africa
contin
poor
human
financi
resourc
weak
healthcar
infrastructur
surveil
antimicrobi
resist
result
repeat
prophylact
antibiot
use
among
hiv
posit
individu
clinic
impact
investig
futur
studi
research
also
need
investig
effect
vaccin
respiratori
pathogen
among
hiv
posit
individu
review
interpret
consider
certain
limit
first
common
review
type
found
high
heterogen
studi
explain
age
group
howev
unabl
investig
sourc
due
inconsist
report
covari
throughout
includ
studi
second
variou
unsd
subregion
africa
proport
repres
review
may
hinder
translat
find
entir
contin
third
includ
studi
observ
could
lead
bia
unmeasur
confound
hiv
posit
neg
nonetheless
best
knowledg
first
systemat
review
metaanalysi
given
clear
accur
estim
cfr
among
hiv
posit
individu
arti
compar
hivneg
arti
also
first
investig
associ
hiv
infect
specif
respiratori
viral
aetiolog
arti
search
biggest
electron
databas
use
rigor
methodolog
statist
procedur
gener
estim
studi
assess
low
moder
risk
bia
methodolog
qualiti
suggest
confid
qualiti
estim
inde
sensit
analysi
includ
low
risk
bia
studi
yield
estim
close
crude
analysi
cfr
analysi
also
consid
studi
use
polymeras
chain
reaction
diagnost
method
viral
aetiolog
arti
systemat
review
metaanalysi
show
increas
risk
death
among
hivposit
individu
arti
compar
hiv
neg
arti
control
counterpart
especi
among
children
year
howev
differ
viral
aetiolog
arti
infect
hiv
posit
hiv
neg
individu
africa
arti
deserv
attent
hiv
healthcar
provid
research
polici
maker
stakehold
overal
proper
manag
effici
control
arti
peopl
hiv
africa
specif
strategi
need
hivposit
children
data
gener
analys
studi
includ
publish
articl
supplementari
inform
file
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
requir
author
declar
compet
interest
